CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CRBU

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	05:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc
2024/05/08	05:05	GlobeNewswire Inc.	Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CRBU	Caribou Biosciences Inc
2024/05/02	05:05	GlobeNewswire Inc.	Caribou Biosciences to Participate in Upcoming Investor Conferences	NASDAQ:CRBU	Caribou Biosciences Inc
2024/04/24	23:00	GlobeNewswire Inc.	Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:CRBU	Caribou Biosciences Inc
2024/04/15	22:00	GlobeNewswire Inc.	Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)	NASDAQ:CRBU	Caribou Biosciences Inc
2024/04/05	05:00	GlobeNewswire Inc.	Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus	NASDAQ:CRBU	Caribou Biosciences Inc
2024/03/12	06:08	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CRBU	Caribou Biosciences Inc
2024/03/12	05:25	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CRBU	Caribou Biosciences Inc
2024/03/12	05:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc
2024/03/12	05:05	GlobeNewswire Inc.	Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CRBU	Caribou Biosciences Inc
2024/03/06	06:30	GlobeNewswire Inc.	Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	07:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	07:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	07:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	07:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	07:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	07:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	07:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/23	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/16	06:05	GlobeNewswire Inc.	Caribou Biosciences to Participate in Upcoming Investor Conferences	NASDAQ:CRBU	Caribou Biosciences Inc
2024/02/09	07:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/01/11	06:18	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:CRBU	Caribou Biosciences Inc
2024/01/10	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/01/10	06:07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/01/09	06:18	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CRBU	Caribou Biosciences Inc
2024/01/08	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc
2024/01/08	01:00	GlobeNewswire Inc.	Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024	NASDAQ:CRBU	Caribou Biosciences Inc
2023/12/23	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc